CHA
RGEN icon

Carmichael Hill & Associates’s Repligen RGEN Stock Holding History

Carmichael Hill & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20
Closed -$4K – 830
2022
Q3 		$4K Hold
20
– – ﹤0.01% 705
2022
Q2 		$3K Hold
20
– – ﹤0.01% 709
2022
Q1 		$4K Hold
20
– – ﹤0.01% 708
2021
Q4 		$5K Hold
20
– – ﹤0.01% 708
2021
Q3 		$6K Buy
+20
New +$5.13K ﹤0.01% 674

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Carmichael Hill & Associates's RGEN Position: Q4 2022 in Review

Carmichael Hill & Associates sold out of Repligen (RGEN) in Q4 2022, closing a stake of 20 shares — an estimated $4K sold.

Carmichael Hill & Associates first reported a position in RGEN in Q3 2021 and held it in 5 quarters. The position peaked at $6K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Carmichael Hill & Associates reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Carmichael Hill & Associates sold 20 Repligen shares in Q4 2022, an estimated $4K.
  • Carmichael Hill & Associates first reported a position in Repligen in Q3 2021 and held it in 5 quarters.
  • Carmichael Hill & Associates's Repligen position peaked at $6K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Carmichael Hill & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.